Home > Back to Publisher > Report Information

Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

GBI Research
February 14, 2012
76 Pages - SKU: XGBR6820259

Abstract Table of Contents Search inside this report Related Reports

Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

Summary

GBI Research’s report, “Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator”, provides key data, information and analysis on the global rapid tests and point of care (POC) market. The report provides information on the market landscape, the competitive landscape and market trend information on three rapid tests and POC market categories: clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests. The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market’s dynamics. The report also provides profiles of the major companies operating in the rapid tests and POC market and a detailed analysis of the pipeline products in each category. Furthermore, the report reviews the details of important merger and acquisition deals that have taken place in the rapid tests and POC market over the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Scope

Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
The market size of three rapid tests and POC market categories - clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests.
Annualized market revenue data from 2003 to 2010, forecast forward for 7 years to 2017.
Qualitative analysis of key market trends, market drivers and restraints of each category within the rapid tests and POC market.
The report also covers information on the leading players in the market and the leading technologies.

Reasons to buy

Develop business strategies by understanding the trends and developments that are driving the global rapid tests and POC market.
Design and develop your product’s development, marketing and sales strategies.
Exploit M&A opportunities by identifying market the players with the most innovative pipeline.
Develop market entry and market expansion strategies.
Identify the key players best positioned to take advantage of emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
What’s the next big thing in the rapid tests and POC market landscape? Identify, understand and capitalize.
Make more informed business decisions with the aid of insightful and in-depth analysis of the global rapid tests and POC market and the factors shaping it.

Additional Information

GBI Research’s report, “Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator”, provides key data, information and analysis on the global rapid tests and point of care (POC) market. The report provides information on the market landscape, the competitive landscape and market trend information on three rapid tests and POC market categories: clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests. The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market’s dynamics. The report also provides profiles of the major companies operating in the rapid tests and POC market and a detailed analysis of the pipeline products in each category. Furthermore, the report reviews the details of important merger and acquisition deals that have taken place in the rapid tests and POC market over the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Rapid Tests and Point of Care Market Forecast to Increase at a CAGR of 7% During the Period 2010 - 2017

The global rapid tests and point of care market was valued at $4.7 billion in 2010 and is forecast to grow to $7.4 billion by 2017, registering a compound annual growth rate (CAGR) of 7% during the period 2010 - 2017. The market is forecast to be driven by a growing focus on emerging countries, an increase in government initiatives in emerging countries to provide quality healthcare, increasing healthcare expenditure, an increase in the percentage of the population needing critical care, an increase in the prevalence of infectious diseases and an increase in research and development activity, which will lead to the introduction of more innovative products and test menu expansion.

Significant Consolidation in Recent Years to Reshape the Competitive Landscape in the Industry

The rapid tests and point of care testing market has witnessed a significant increase in merger and acquisition activity over the past few years. There are around 15 major deals that have taken place in the market since the beginning of 2009 and the industry’s consolidation is changing the competitive landscape and the dynamics of the market.

In the case of the POC market, acquisitions help companies to strengthen their product portfolio by means of test menu expansion or technology expansion. Furthermore, acquisitions enable companies to expand their market by entering into new geographical areas.

For example, the acquisition of Beckman Coulter by Danaher enabled Danaher to expand its portfolio in test menus, gain new technology and also expand geographically. Similarly, Murex was acquired by DiaSorin in 2010, an acquisition which enabled DiaSorin to add new depth to its product portfolio and further strengthen its leadership position in the field of rapid tests for infectious diseases.

Alere has taken a leading position in the European drug testing market by acquiring Concateno, an acquisition which enabled Alere to maintain its dominance in several product segments. In 2010, the acquisition of Korea - based Standard Diagnostics gave Alere increased exposure to the Korean and Indian markets and allowed for distribution of the organically developed Pima CD4 Analyzer to the sub - Saharan region of Africa.

Further consolidation took place in 2011, with ARGENE being acquired by BioMerieux. ARGENE has a wide range of reagents for rapid tests in the field of molecular biology, which has enabled BioMerieux to expand its technology and menu in molecular diagnostics.

Clinical Chemistry Rapid Tests and POC to Continue to be the Largest Segment in the Global Rapid Tests and Point of Care Market

In 2010, the global clinical chemistry rapid tests and POC segment accounted for 62% of the overall rapid tests and POC market and was valued at $2.9 billion. It is forecast to grow at a CAGR of 6.3% over the period 2010-2017, to reach a market value of $4.4 billion in 2017. Technological advances in recent years have helped clinical chemistry rapid tests and POC to emerge as vital diagnostic tools, and have enabled medical diagnosis to operate in every healthcare setting. There are several factors that have contributed to the growth of the clinical chemistry rapid tests and POC market, such as the increasing age of the population and increasing rates of obesity - obesity and old age are the major risk factors for chronic diseases. Chronic diseases are more common in elderly and obese people, due to which there has been an increase in the prevalence of chronic diseases which require frequent testing, such as coagulation analysis and blood sugar analysis, in recent years. POC tests give results in a short time, which helps to achieve timely treatment, thus improving patient outcomes. POC tests also make a patient’s treatment more convenient and fast, leading to better healthcare for people across the world. These advantages will drive the growth of the clinical chemistry rapid tests and POC segment over the coming years.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 GBI Research Guidance
3 Global Rapid Tests and Point of Care Market - Market Characterization: 3.1 Global Rapid Tests and Point of Care Market, Revenue ($m), 2003 - 2010; 3.2 Global Rapid Tests and Point of Care Market, Revenue ($m), 2010 - 2017; 3.3 Global Rapid Tests and Point of Care Market, Key Market Trends; 3.4 Significant Consolidation in Recent Years to Reshape the Competitive Landscape of the Industry; 3.5 Global Rapid Tests and Point of Care, Market Dynamics
4 Global Rapid Tests and Point of Care Market - Market Category Analysis and Forecasts: 4.1 Clinical Chemistry Rapid Tests and POC; 4.2 Clinical Chemistry Rapid Tests and POC Market - Market Dynamics; 4.3 Immunochemistry Rapid Tests Market; 4.4 Immunochemistry Rapid Tests Market - Market Dynamics; 4.5 Hematology Rapid Tests Market; 4.6 Hematology Rapid Tests Market - Market Dynamics
5 Global Rapid Tests and Point of Care Market - Country Analysis and Forecasts: 5.1 Rapid Tests and Point of Care Market - Cross - Country Analysis; 5.2 Revenue Forecasts, by Country, 2003 - 2017
6 Global Rapid Tests and Point of Care Market - Key Market Participants: 6.1 F. Hoffmann - La Roche Ltd.; 6.2 Abbott Laboratories; 6.3 Siemens Healthcare (Subsidiary of Siemens AG); 6.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation); 6.5 bioMerieux S.A. (Subsidiary of Merieux Alliance Group); 6.6 DiaSorin S.p.A
7 Global Rapid Tests and Point of Care Market - Product Pipeline Analysis: 7.1 Rapid Tests and Point of Care Market - Pipeline Product Summary; 7.2 Rapid Tests and Point of Care Market - List of Pipeline Products; 7.3 Rapid Tests and Point of Care - Profiles of Key Pipeline Products
8 Global Rapid Tests and Point of Care Market - Consolidation Landscape: 8.1 Rapid Tests and Point of Care Market - Key Deals 2011; 8.2 Rapid Tests and Point of Care Market - Key Deals, 2007 - 2010
9 Appendix: 9.1 Definitions; 9.2 Acronyms; 9.3 Research Methodology; 9.4 Contact Us; 9.5 Disclaimer; 9.6 Sources
1.1 List of Tables: Table 1: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003 - 2010; Table 2: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010 - 2017; Table 3: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003 - 2010; Table 4: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010 - 2017; Table 5: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 - 2010; Table 6: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010 - 2017; Table 7: Hematology Rapid Tests Market, Global, Revenue ($m), 2003 - 2010; Table 8: Hematology Rapid Tests Market, Global, Revenue ($m), 2010 - 2017; Table 9: Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003 - 2017; Table 10: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 - 2010; Table 11: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 - 2017; Table 12: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 - 2010; Table 13: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 - 2017; Table 14: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 - 2010; Table 15: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 - 2017; Table 16: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003 - 2010; Table 17: Rapid Tests and Point of Care Market, the Germany, Revenue ($m), 2010 - 2017; Table 18: Rapid Tests and Point of Care Market, France, Revenue ($m), 2003 - 2010; Table 19: Rapid Tests and Point of Care Market, France, Revenue ($m), 2010 - 2017; Table 20: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003 - 2010; Table 21: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010 - 2017; Table 22: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003 - 2010; Table 23: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010 - 2017; Table 24: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003 - 2010; Table 25: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010 - 2017; Table 26: Rapid Tests and Point of Care Market, China, Revenue ($m), 2003 - 2010; Table 27: Rapid Tests and Point of Care Market, China, Revenue ($m), 2010 - 2017; Table 28: Rapid Tests and Point of Care Market, India, Revenue ($m), 2003 - 2010; Table 29: Rapid Tests and Point of Care Market, India, Revenue ($m), 2010 - 2017; Table 30: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003 - 2010; Table 31: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010 - 2017; Table 32: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010; Table 33: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010 - 2017; Table 34: Rapid Tests and Point of Care Market, Global, Pipeline Product Summary, 2010; Table 35: Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage; Table 36: Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010 - 2011; Table 37: Rapid Test and Point of Care Market, Global, List of Pipeline Products, 2010 - 2012; Table 38: ImmProCon Technology, Product Status, 2011; Table 39: RAPIDPoint 500 System, Product Status, 2011; Table 40: Sali - Chek Reader, Product Status, 2011; Table 41: Point Of Care Diagnostic Device, Product Status, 2011; Table 42: ACE Alera Clinical Chemistry System - Direct A1c Assay, Product Status, 2011; Table 43: Advia 120 Hematology System - IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011; Table 44: Advia 2120 Hematology System - MPC (Mean Platelet Component) Test, Product Status, 2011; Table 45: AIA (Automated Immunoassay Analyzer) - 600 II - D - dimer Test, Product Status, 2011
1.2 List of Figures: Figure 1: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003 - 2010; Figure 2: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010 - 2017; Figure 3: Rapid Tests and Point of Care Market, Market Categorization and Segmentation; Figure 4: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003 - 2010; Figure 5: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010 - 2017; Figure 6: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 - 2010; Figure 7: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010 - 2017; Figure 8: Hematology Rapid Tests Market, Global, Revenue ($m), 2003 - 2010; Figure 9: Hematology Rapid Tests Market, Global, Revenue ($m), 2010 - 2017; Figure 10: Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003 - 2017; Figure 11: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 - 2010; Figure 12: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 - 2017; Figure 13: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 - 2010; Figure 14: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 - 2017; Figure 15: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 - 2010; Figure 16: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 - 2017; Figure 17: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003 - 2010; Figure 18: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010 - 2017; Figure 19: Rapid Tests and Point of Care Market, France, Revenue ($m), 2003 - 2010; Figure 20: Rapid Tests and Point of Care Market, France, Revenue ($m), 2010 - 2017; Figure 21: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003 - 2010; Figure 22: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010 - 2017; Figure 23: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003 - 2010; Figure 24: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010 - 2017; Figure 25: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003 - 2010; Figure 26: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010 - 2017; Figure 27: Rapid Tests and Point of Care Market, China, Revenue ($m), 2003 - 2010; Figure 28: Rapid Tests and Point of Care Market, China, Revenue ($m), 2010 - 2017; Figure 29: Rapid Tests and Point of Care Market, India, Revenue ($m), 2003 - 2010; Figure 30: Rapid Tests and Point of Care Market, India, Revenue ($m), 2010 - 2017; Figure 31: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003 - 2010; Figure 32: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010 - 2017; Figure 33: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010; Figure 34: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010 - 2017; Figure 35: Rapid Tests and Point of Care Market, Global, Pipeline Product Summary (%), 2010; Figure 36: Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage

Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

Share this report

Other tasks

Research Assistance

Related Markets

Point-of-Care Reports

Free Alert Me service